Since the suggested mechanism elucidating the association between the EAT and AF is mainly that EAT contributes to a remodeled atrial substrate (14), the lower efficacy of a POBI (i.e., substrate modification) among patients with a large EAT observed in this study appears to be a paradox. The gene discussed is MCL1; the disease is atrial fibrillation.